Literature DB >> 3172991

A simplified approach to the analysis of subclasses of phospholipids: application to human platelets.

I Vishnubhatla1, M Kates, G A Adams.   

Abstract

A procedure for the determination of the proportions of diacyl, alkenylacyl and alkylacyl subclasses of glycerophospholipids was developed. The procedure involves: (1) acid methanolysis of the phospholipid followed by Bligh/Dyer extraction of fatty acid methyl esters (FAME) derived from acyl chain types, dimethylacetals (DMA) derived from alkenyl ether chain types, and lysoalkyl phosphatidic acids (lysoalkyl-PA) derived from alkyl ether chain types; and (2) subsequent acetolysis to convert the lysoalkyl-PA to monoalkyl glycerol diacetates (MAGD). GLC analysis and quantitation (using internal standard, 21:0 FAME) of FAME, DMA and MAGD allowed calculation of the proportions of the three molecular subclasses. The methanolysis/acetolysis procedure gave an overall mean phospholipid recovery of 95 +/- 3%. Analysis of the major phospholipids in four separate preparations of fresh resting human platelets by this procedure showed the following range of molecular subclasses: phosphatidylcholine (PC), 86-92 mol % diacyl, 6-10 mol % alkylacyl and 2-3 mol % alkenylacyl; and phosphatidylethanoline (PE), 39-60 mol % diacyl, 5-8 mol % alkylacyl and 34-55 mol % alkenylacyl. The results of these subclass analyses were in general agreement with those reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3172991     DOI: 10.1007/bf02535606

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  24 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

Review 2.  Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids.

Authors:  F Snyder
Journal:  Med Res Rev       Date:  1985 Jan-Mar       Impact factor: 12.944

3.  Preparation of suspensions of washed platelets from humans.

Authors:  J F Mustard; D W Perry; N G Ardlie; M A Packham
Journal:  Br J Haematol       Date:  1972-02       Impact factor: 6.998

4.  Separation and quantitation of phospholipid subclasses as their diradylglycerobenzoate derivatives by normal-phase high-performance liquid chromatography.

Authors:  M L Blank; E A Cress; F Snyder
Journal:  J Chromatogr       Date:  1987-04-17

5.  Separation of alkenylacyl, alkylacyl, and diacyl analogues and their molecular species by high performance liquid chromatography.

Authors:  Y Nakagawa; L A Horrocks
Journal:  J Lipid Res       Date:  1983-09       Impact factor: 5.922

6.  Ether lipid content and fatty acid distribution in rabbit polymorphonuclear neutrophil phospholipids.

Authors:  H W Mueller; J T O'Flaherty; R L Wykle
Journal:  Lipids       Date:  1982-02       Impact factor: 1.880

7.  1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.

Authors:  H W Mueller; A D Purdon; J B Smith; R L Wykle
Journal:  Lipids       Date:  1983-11       Impact factor: 1.880

8.  Lipid composition of freshly prepared and stored platelet concentrates.

Authors:  M A Hamid; T J Kunicki; R H Aster
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

9.  Altered phospholipid composition of plasma membranes from thrombin-stimulated human platelets.

Authors:  C M Skeaff; B J Holub
Journal:  Biochim Biophys Acta       Date:  1985-04-25

10.  Separation of phospholipids and individual molecular species of phospholipids by high-performance liquid chromatography.

Authors:  G M Patton; J M Fasulo; S J Robins
Journal:  J Lipid Res       Date:  1982-01       Impact factor: 5.922

View more
  1 in total

1.  Alk-1-enylacyl, alkylacyl, and diacyl subclasses of native ethanolamine and choline glycerophospholipids can be quantified directly by phosphorus-31 NMR in solution.

Authors:  B Malewicz; W J Baumann
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.